Posizioni attive di Matthew Bartholomae
| Società | Posizione | Inizio | Fine |
|---|
Storia della carriera di Matthew Bartholomae
Precedenti posizioni note di Matthew Bartholomae
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CARTESIAN THERAPEUTICS, INC. | Consigliere Generale | 01/12/2020 | 01/11/2023 |
| Segretario Aziendale | 01/12/2020 | 01/11/2023 | |
| MINERVA NEUROSCIENCES, INC. | Corporate Officer/Principal | 01/01/2016 | 01/01/2018 |
Formazione di Matthew Bartholomae
| Boston College | Undergraduate Degree |
| University of New Hampshire School of Law | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| General Counsel | 2 |
| Corporate Secretary | 2 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MINERVA NEUROSCIENCES, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
- Borsa valori
- Insiders
- Matthew Bartholomae
- Esperienza
